Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Medical - Care Facilities

Healthcare
$29.36 +0.00%

+$0.00 today

Market cap
$445.55M
Beta
0.00
P/E (TTM)
414.6
EPS (TTM)
$0.07
52W Low $4.30High $31.70

Volume 0.00M

Average 0.87M

MCTA Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA

Net Debt · Q4 FY2024 · quarter ended Mar 2025

Net debt turns positive

Q4 FY2024 net debt was $343.87K, compared with -$1.14M a year earlier.

Context

  • Net debt amounted to 6.4% of total assets at the end of Q4 FY2024, down 17.0 pp from a year earlier.
  • Net debt increased in 1 of the last 2 fiscal years.
  • FY2024 was the highest annual figure in the 3 fiscal years shown.

What to watch

Whether net debt keeps rising in the next quarterly balance sheet after a +130.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2025
$343.87K— QoQ
Last fiscal yearMar 2025
$343.87K+130.1% YoY
Year agoMar 2024
-$1.14M+130.1% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+130.1%——
1 year+130.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2024
343.87K USD
Year-over-year change
+130.1%

Net Debt vs competitors

How MCTA compares with its peers on the latest reported figures

  • MCTA's Mar 2025 net debt of $343.87K is the 3rd highest of the 10 companies compared; the peer median is -$40.41M.
  • Its year-over-year change of +130.1% is the 2nd highest of 10, against a peer median of -33.8%.
  • Net debt amounts to 6.4% of total assets for MCTA, versus a peer median of 23.0%.
MCTA Competitors Peer median
Net Debt for MCTA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NAKANakamoto Inc.Mar 2026$174.44M +36887.6%+871.7%28.1%
TOIThe Oncology Institute, Inc.Mar 2026$74.58M +19.2%-9.4%44.3%
MCTACharming Medical Limited Class A Ordinary SharesMar 2025$343.87K +130.1%—6.4%
RXSTRxSight, Inc.Mar 2026-$6.75M +57.7%—2.2%
SLPSimulations Plus, Inc.Feb 2026-$25.22M -147.3%—17.2%
DCTHDelcath Systems, Inc.Mar 2026-$40.41M -243.6%—32.4%
TCMDTactile Systems Technology, Inc.Mar 2026-$59.82M -49.6%—22.0%
CCRNCross Country Healthcare, Inc.Mar 2026-$103.54M -33.8%—23.0%
AGLAgilon Health, Inc.Mar 2026-$106.59M -10.3%—7.1%
ANNXAnnexon, Inc.Mar 2026-$149.77M -117.7%—57.0%
Peer median (excluding MCTA) -$40.41M-33.8%+431.2%23.0%

Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
Cash & Equivalents1.93M2.1M816.77K
Short-term Investments001.94M
Net Receivables2.12M1.54M579.09K
Inventory66.33K28.15K26.8K
Other Current Assets000
Total Current Assets4.12M3.67M3.37M
Property, Plant & Equipment (Net)1.8M921.86K1.21M
Goodwill000
Intangible Assets000
Long-term Investments000
Tax Assets272.77K211.14K77.29K
Other Non-current Assets193.75K81.44K700.64K
Total Non-current Assets2.26M1.21M1.99M
Total Assets6.38M4.88M5.36M
Account Payables1.57K03.48K
Short-term Debt589.66K442.61K314.23K
Tax Payables0119.25K221.34K
Deferred Revenue5.6M4.5M3.46M
Other Current Liabilities000
Total Current Liabilities7.17M5.88M4.95M
Long-term Debt000
Deferred Tax Liabilities000
Deferred Revenue (Non-current)000
Other Non-current Liabilities000
Total Non-current Liabilities484.26K148.25K358.03K
Total Liabilities7.65M6.03M5.31M
Common Stock1.53K1.53K1.53K
Retained Earnings(1.16M)(1.08M)119.44K
Accumulated OCI3.92K205(3.57K)
Other Stockholders Equity(381.04K)(381.04K)(381.04K)
Minority Interest(110.21K)(66.63K)0
Total Equity(1.27M)(1.15M)49.24K
Total Debt1.81M961.38K1.16M
Net Debt(119.68K)(1.14M)343.87K

Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Intrinsic Alpha fair value

Locked

Current Price

$29.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.